Q9Y6G9 (DC1L1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 102.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Cytoplasmic dynein 1 light intermediate chain 1 Short name=LIC1 Alternative name(s): Dynein light chain A Short name=DLC-A Dynein light intermediate chain 1, cytosolic | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 523 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in binding dynein to membranous organelles or chromosomes. Probably involved in the microtubule-dependent transport of pericentrin. Is required for progress throuh the spindle assembly checkpoint. The phosphorylated form appears to be involved in the selective removal of MAD1L1 and MAD1L2 but not BUB1B from kinetochores. Ref.11 |
| Subunit structure | Homodimer By similarity. The cytoplasmic dynein 1 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs); the composition seems to vary in respect to the IC, LIC and LC composition. The heavy chain homodimer serves as a scaffold for the probable homodimeric assembly of the respective non-catalytic subunits. The ICs and LICs bind directly to the HC dimer and the LCs assemble on the IC dimer. Self-associates. Interacts with DYNC1H1; DYNC1LI1 and DYNC1LI2 bind mutually exclusive to DYNC1H1. Interacts with PCNT By similarity. Interacts with human adenovirus 5 hexon protein; this interaction probably allows virus intracellular transport. Ref.11 Ref.12 |
| Subcellular location | Cytoplasm By similarity. Chromosome › centromere › kinetochore. Cytoplasm › cytoskeleton › spindle pole Ref.11. |
| Post-translational modification | Phosphorylated during mitosis but not in interphase. Ref.11 |
| Sequence similarities | Belongs to the dynein light intermediate chain family. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 523 | 523 | Cytoplasmic dynein 1 light intermediate chain 1 | PRO_0000114666 | |||||
Regions | |||||||||
| Nucleotide binding | 74 – 81 | 8 | ATP Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 207 | 1 | Phosphoserine Ref.5 Ref.8 Ref.9 Ref.10 Ref.11 Ref.14 Ref.15 Ref.17 | ||||||
| Modified residue | 213 | 1 | Phosphothreonine Ref.10 | ||||||
| Modified residue | 398 | 1 | Phosphoserine Ref.9 Ref.11 Ref.15 | ||||||
| Modified residue | 405 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 408 | 1 | Phosphothreonine Ref.11 | ||||||
| Modified residue | 412 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 414 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 419 | 1 | Phosphoserine Ref.10 Ref.15 | ||||||
| Modified residue | 421 | 1 | Phosphoserine Ref.10 Ref.15 | ||||||
| Modified residue | 450 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 487 | 1 | Phosphoserine Ref.9 Ref.15 | ||||||
| Modified residue | 510 | 1 | Phosphoserine Ref.10 Ref.14 | ||||||
| Modified residue | 512 | 1 | Phosphothreonine Ref.10 Ref.14 | ||||||
| Modified residue | 513 | 1 | Phosphothreonine Ref.10 Ref.14 | ||||||
| Modified residue | 515 | 1 | Phosphothreonine Ref.10 Ref.14 | ||||||
| Modified residue | 516 | 1 | Phosphoserine Ref.10 Ref.14 Ref.15 Ref.17 | ||||||
| Modified residue | 518 | 1 | Phosphothreonine By similarity | ||||||
Natural variations | |||||||||
| Natural variant | 147 | 1 | M → T. Corresponds to variant rs34181332 [ dbSNP | Ensembl ]. | VAR_061141 | |||||
| Natural variant | 277 | 1 | Q → R. Ref.1 Ref.2 Corresponds to variant rs2303857 [ dbSNP | Ensembl ]. | VAR_023325 | |||||
Experimental info | |||||||||
| Sequence conflict | 186 | 1 | M → I in BAD96293. Ref.2 | ||||||
| Sequence conflict | 210 | 1 | R → G in BAD96293. Ref.2 | ||||||
| Sequence conflict | 225 | 1 | L → V in AAD44481. Ref.1 | ||||||
| Sequence conflict | 267 | 1 | I → F in AAD44481. Ref.1 | ||||||
| Sequence conflict | 351 | 1 | D → G in BAD96293. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human dynein light chain-A mRNA, complete cds." Dai M., Peng Y., Song H., Huang Q., Mao Y., Zhang Q., Mao M., Fu G., Luo M., Chen J., Hu R. Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT ARG-277. Tissue: Pituitary. |
| [2] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ARG-277. Tissue: Cerebellum and Coronary artery. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [5] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [6] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [7] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [8] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-398 AND SER-487, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; THR-213; SER-419; SER-421; SER-510; THR-512; THR-513; THR-515 AND SER-516, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Dynein light intermediate chain 1 is required for progress through the spindle assembly checkpoint." Sivaram M.V., Wadzinski T.L., Redick S.D., Manna T., Doxsey S.J. EMBO J. 28:902-914(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN THE SPINDLE ASSEMBLY CHECKPOINT, SUBUNIT, PHOSPHORYLATION AT SER-207; SER-398; SER-405 AND THR-408, SUBCELLULAR LOCATION. |
| [12] | "Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit." Bremner K.H., Scherer J., Yi J., Vershinin M., Gross S.P., Vallee R.B. Cell Host Microbe 6:523-535(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HUMAN ADENOVIRUS HEXON PROTEIN. |
| [13] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [14] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-510; THR-512; THR-513; THR-515 AND SER-516, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [15] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-398; SER-419; SER-421; SER-487 AND SER-516, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [17] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207 AND SER-516, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF078849 mRNA. Translation: AAD44481.1. AK222573 mRNA. Translation: BAD96293.1. AK222653 mRNA. Translation: BAD96373.1. CH471055 Genomic DNA. Translation: EAW64433.1. BC131620 mRNA. Translation: AAI31621.1. |
| IPI | IPI00007675. |
| RefSeq | NP_057225.2. NM_016141.3. |
| UniGene | Hs.529495. |
3D structure databases | |
| ProteinModelPortal | Q9Y6G9. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9Y6G9. 9 interactions. |
| STRING | 9606.ENSP00000273130. |
PTM databases | |
| PhosphoSite | Q9Y6G9. |
Polymorphism databases | |
| DMDM | 134047749. |
Proteomic databases | |
| PaxDb | Q9Y6G9. |
| PRIDE | Q9Y6G9. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000273130; ENSP00000273130; ENSG00000144635. |
| GeneID | 51143. |
| KEGG | hsa:51143. |
| UCSC | uc003cfb.4. human. |
Organism-specific databases | |
| CTD | 51143. |
| GeneCards | GC03M032543. |
| HGNC | HGNC:18745. DYNC1LI1. |
| HPA | HPA035013. |
| neXtProt | NX_Q9Y6G9. |
| PharmGKB | PA38670. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG265404. |
| HOGENOM | HOG000236263. |
| HOVERGEN | HBG005546. |
| InParanoid | Q9Y6G9. |
| KO | K10416. |
| OMA | RISRKPE. |
| OrthoDB | EOG4W3SN1. |
| PhylomeDB | Q9Y6G9. |
Gene expression databases | |
| ArrayExpress | Q9Y6G9. |
| Bgee | Q9Y6G9. |
| CleanEx | HS_DYNC1LI1. |
| Genevestigator | Q9Y6G9. |
| GermOnline | ENSG00000144635. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR008467. Dynein1_light_intermed_chain. IPR022780. Dynein_light_int_chain. IPR027417. P-loop_NTPase. [Graphical view] |
| PANTHER | PTHR12688. PTHR12688. 1 hit. |
| Pfam | PF05783. DLIC. 1 hit. [Graphical view] |
| SUPFAM | SSF52540. SSF52540. 1 hit. |
| ProtoNet | Search... |
Other | |
| ChiTaRS | DYNC1LI1. human. |
| GenomeRNAi | 51143. |
| NextBio | 54004. |
Entry information
| Entry name | DC1L1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y6G9 Secondary accession number(s): A2RRG7, Q53HC8, Q53HK7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| SIMILARITY comments Index of protein domains and families |

Clusters with
